Full-field digital mammography (FFDM) captured the lion’s share of attention during the 2004 RSNA meeting. As expected, Siemens Medical Solutions showed its Mammomat Novation as a marketable product, while several other manufacturers reappeared with upgraded products or works-in-progress.
Full-field digital mammography (FFDM) captured the lion's share of attention during the 2004 RSNA meeting. As expected, Siemens Medical Solutions showed its Mammomat Novation as a marketable product, while several other manufacturers reappeared with upgraded products or works-in-progress.
Pressing forward with their own full-field systems were Giotto and Planmed. Both hope to show commercially available versions of their products during the 2005 RSNA meeting.
Following Hologic's lead during the 2003 RSNA show, tomosynthesis made inroads, though the capability appears to be at least 18 months from commercialization. This year, Siemens also showed tomosynthesis as a work-in-progress.
As FFDM has matured, dedicated mammography workstations continue to proliferate, with most manufacturers offering their own stations or partnering to provide the capability.
An independent provider of medical imaging technologies, Cedara deploys its software in hospitals and clinics worldwide, while licensing OEM versions for use in privately labeled imaging systems and information technologies.
Founded to develop and commercialize imaging technologies designed to improve the diagnosis of cancer and other diseases, Dobi has developed the ComfortScan system. The digital imaging device, designed to provide information that may significantly enhance breast cancer diagnosis, is based on optical imaging technology.
The company designs, manufactures, and markets medical imaging systems for screening and diagnosing disease. It focuses on women's health, particularly the detection of breast cancer through the application of digital imaging technologies.
With 70 years of imaging experience and $20 billion in sales behind it, Fujifilm continues its transition from a film- to an electronics-based company. In recent years, the company has striven to present turnkey imaging solutions in radiography and mammography.
The company's expertise in medical imaging and information technologies, medical diagnostics, and patient monitoring systems is dedicated to detecting disease early so as to tailor treatment to each patient. The goal is to provide transformational medical technologies that improve patient care.
Established in 2003, Giotto USA is dedicated to the sale of mammography systems in the U.S. and Puerto Rico.
The company has made women's health a priority. It also serves as a supplier of digital imaging technology for OEMs in both mammography and radiography.
Konica Minolta is a manufacturer and distributor of digital and traditional imaging products for diagnostic use by hospitals, imaging centers, clinics, and private practice physicians.
Royal Philips Electronics is one of the world's largest electronics companies, with interests in three interlocking domains: healthcare, lifestyle, and technology. It competes with GE and Siemens for market leadership in various areas of medical diagnostic imaging.
Planmed manufactures and markets advanced imaging products within the medical field. The company's mammography equipment is known for its ergonomics and tailored features.
Like GE and Philips, Siemens is a multimodality imaging leader with a reputation for consistency. Its solutions range from imaging and therapy equipment to electromedical instruments.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.